XML 50 R31.htm IDEA: XBRL DOCUMENT v3.7.0.1
Fair Value (Tables)
6 Months Ended
Jun. 30, 2017
Fair Value Disclosures [Abstract]  
Fair value hierarchy
The following table presents the Company’s financial assets and liabilities measured at fair value by level at June 30, 2017:
 
 
 
Estimated Fair Value Measurements Using:
 
Estimated
Fair
Value
 
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Assets measured at fair value (1):
 

 
 

 
 

 
 

Available for sale securities:
 

 
 

 
 

 
 

Fixed maturities:
 

 
 

 
 

 
 

Corporate bonds
$
4,262,411

 
$

 
$
4,250,841

 
$
11,570

Mortgage backed securities
331,082

 

 
331,082

 

Municipal bonds
2,618,827

 

 
2,618,827

 

Commercial mortgage backed securities
521,272

 

 
521,272

 

U.S. government and government agencies
3,425,196

 
3,360,752

 
64,444

 

Non-U.S. government securities
1,375,796

 

 
1,375,796

 

Asset backed securities
1,739,695

 

 
1,739,695

 

Total
14,274,279

 
3,360,752

 
10,901,957

 
11,570

 
 
 
 
 
 
 
 
Equity securities
467,870

 
463,015

 
4,855

 

 
 
 
 
 
 
 
 
Short-term investments
914,356

 
906,191

 
8,165

 

 
 
 
 
 
 
 
 
Other investments
170,402

 
170,402

 

 

Other investments measured at net asset value (2)
78,259

 
 
 
 
 
 
Total other investments
248,661

 
170,402

 

 

 
 
 
 
 
 
 
 
Derivative instruments (4)
30,215

 

 
30,215

 

 
 
 
 
 
 
 
 
Fair value option:
 
 
 
 
 
 
 
Corporate bonds
749,399

 

 
749,399

 

Non-U.S. government bonds
75,084

 

 
75,084

 

Mortgage backed securities
19,812

 

 
19,812

 

Asset backed securities
16,291

 

 
16,291

 

U.S. government and government agencies
209,583

 
209,583

 

 

Short-term investments
527,384

 
524,167

 
3,217

 

Equity securities
76,915

 
57,523

 
19,392

 

Other investments
1,392,973

 
92,860

 
1,275,113

 
25,000

Other investments measured at net asset value (2)
750,792

 
 
 
 
 
 
Total
3,818,233

 
884,133

 
2,158,308

 
25,000

 
 
 
 
 
 
 
 
Total assets measured at fair value
$
19,753,614

 
$
5,784,493

 
$
13,103,500

 
$
36,570

 
 
 
 
 
 
 
 
Liabilities measured at fair value:
 

 
 

 
 

 
 

Contingent consideration liabilities
$
(57,246
)
 
$

 
$

 
$
(57,246
)
Securities sold but not yet purchased (3)
(69,273
)
 

 
(69,273
)
 

Derivative instruments (4)
(35,004
)
 

 
(35,004
)
 

Total liabilities measured at fair value
$
(161,523
)
 
$

 
$
(104,277
)
 
$
(57,246
)

(1)
In securities lending transactions, the Company receives collateral in excess of the fair value of the securities pledged. For purposes of this table, the Company has excluded the collateral received under securities lending, at fair value and included the securities pledged under securities lending, at fair value. See Note 7, “Investment Information—Securities Lending Agreements.”
(2)
In accordance with applicable accounting guidance, certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheets.
(3)
Represents the Company’s obligations to deliver securities that it did not own at the time of sale. Such amounts are included in “other liabilities” on the Company’s consolidated balance sheets.
(4)
See Note 9, “Derivative Instruments.”
The following table presents the Company’s financial assets and liabilities measured at fair value by level at December 31, 2016:
 
 
 
Estimated Fair Value Measurements Using:
 
Estimated
Fair
Value
 
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Assets measured at fair value (1):
 

 
 

 
 

 
 

Available for sale securities:
 

 
 

 
 

 
 

Fixed maturities:
 

 
 

 
 

 
 

Corporate bonds
$
4,392,373

 
$

 
$
4,374,029

 
$
18,344

Mortgage backed securities
490,093

 

 
490,093

 

Municipal bonds
3,713,434

 

 
3,713,434

 

Commercial mortgage backed securities
536,051

 

 
536,051

 

U.S. government and government agencies
2,804,540

 
2,691,575

 
112,965

 

Non-U.S. government securities
1,096,440

 

 
1,096,440

 

Asset backed securities
1,123,987

 

 
1,112,698

 
11,289

Total
14,156,918

 
2,691,575

 
11,435,710

 
29,633

 
 
 
 
 
 
 
 
Equity securities
532,680

 
529,695

 
2,985

 

 
 
 
 
 
 
 
 
Short-term investments
612,005

 
608,862

 
3,143

 

 
 
 
 
 
 
 
 
Other investments
112,313

 
112,313

 

 

Other investments measured at net asset value (2)
55,657

 
 
 
 
 
 
Total other investments
167,970

 
112,313

 

 

 
 
 
 
 
 
 
 
Derivative instruments (4)
28,410

 

 
28,410

 

 
 
 
 
 
 
 
 
Fair value option:
 
 
 
 
 
 
 
Corporate bonds
790,935

 

 
790,935

 

Non-U.S. government bonds
61,747

 

 
61,747

 

Mortgage backed securities
18,624

 

 
18,624

 

Asset backed securities
30,324

 

 
30,324

 

U.S. government and government agencies
197,486

 
197,486

 

 

Short-term investments
373,669

 
309,127

 
64,542

 

Equity securities
27,642

 
25,328

 
2,314

 

Other investments
1,226,242

 
80,706

 
1,120,536

 
25,000

Other investments measured at net asset value (2)
694,551

 
 
 
 
 
 
Total
3,421,220

 
612,647

 
2,089,022

 
25,000

 
 
 
 
 
 
 
 
Total assets measured at fair value
$
18,919,203

 
$
4,555,092

 
$
13,559,270

 
$
54,633

 
 
 
 
 
 
 
 
Liabilities measured at fair value:
 

 
 

 
 

 
 

Contingent consideration liabilities
$
(122,350
)
 
$

 
$

 
$
(122,350
)
Securities sold but not yet purchased (3)
(33,157
)
 

 
(33,157
)
 

Derivative instruments (4)
(26,049
)
 

 
(26,049
)
 

Total liabilities measured at fair value
$
(181,556
)
 
$

 
$
(59,206
)
 
$
(122,350
)

(1)
In securities lending transactions, the Company receives collateral in excess of the fair value of the securities pledged. For purposes of this table, the Company has excluded the collateral received under securities lending, at fair value and included the securities pledged under securities lending, at fair value. See Note 7, “Investment Information—Securities Lending Agreements.”
(2)
In accordance with applicable accounting guidance, certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheets.
(3)
Represents the Company’s obligations to deliver securities that it did not own at the time of sale. Such amounts are included in “other liabilities” on the Company’s consolidated balance sheets.
(4)
See Note 9, “Derivative Instruments.”
Rollforward of Level 3 investments
The following table presents a reconciliation of the beginning and ending balances for all financial assets and liabilities measured at fair value on a recurring basis using Level 3 inputs:
 
Assets
 
Liabilities
s
Available For Sale
 
Fair Value Option
 
 
 
 
 
Asset Backed Securities
 
Corporate
Bonds
 
Other
Investments
 
Total
 
Contingent Consideration Liabilities
Three Months Ended June 30, 2017
 
 
 

 
 

 
 
 
 
Balance at beginning of period
$
10,637

 
$
18,601

 
$
25,000

 
$
54,238

 
$
(125,544
)
Total gains or (losses) (realized/unrealized)
 
 
 
 
 
 
 
 
 
Included in earnings (1)
3,072

 
636

 

 
3,708

 
(3,441
)
Included in other comprehensive income

 

 

 

 

Purchases, issuances, sales and settlements
 
 
 
 
 
 
 
 
 
Purchases

 
4,935

 

 
4,935

 

Issuances

 

 

 

 

Sales
(13,640
)
 
(12,602
)
 

 
(26,242
)
 

Settlements
(69
)
 

 

 
(69
)
 
71,739

Transfers in and/or out of Level 3

 

 

 

 

Balance at end of period
$

 
$
11,570

 
$
25,000

 
$
36,570

 
$
(57,246
)
 
 
 
 
 
 
 
 
 
 
Three Months Ended June 30, 2016
 
 
 

 
 

 
 

 
 
Balance at beginning of period
$
57,500

 
$
15,166

 
$

 
$
72,666

 
$
(100,710
)
Total gains or (losses) (realized/unrealized)
 
 
 
 
 
 
 
 
 
Included in earnings (1)
(2,500
)
 
1,363

 

 
(1,137
)
 
(10,923
)
Included in other comprehensive income

 

 

 

 
(37
)
Purchases, issuances, sales and settlements
 
 
 
 
 
 
 
 
 
Purchases

 
776

 

 
776

 

Issuances

 

 

 

 

Sales

 

 

 

 

Settlements
(5,789
)
 

 

 
(5,789
)
 

Transfers in and/or out of Level 3

 

 

 

 

Balance at end of period
$
49,211

 
$
17,305

 
$

 
$
66,516

 
$
(111,670
)
 
 
 
 
 
 
 
 
 
 
Six Months Ended June 30, 2017
 
 
 

 
 

 
 
 
 
Balance at beginning of year
$
11,289

 
$
18,344

 
$
25,000

 
$
54,633

 
$
(122,350
)
Total gains or (losses) (realized/unrealized)
 
 
 
 
 
 
 
 
 
Included in earnings (1)
3,779

 
893

 

 
4,672

 
(7,087
)
Included in other comprehensive income

 

 

 

 

Purchases, issuances, sales and settlements
 
 
 
 
 
 
 
 
 
Purchases

 
4,935

 

 
4,935

 

Issuances

 

 

 

 

Sales
(13,640
)
 
(12,602
)
 

 
(26,242
)
 

Settlements
(1,428
)
 

 

 
(1,428
)
 
72,191

Transfers in and/or out of Level 3

 

 

 

 

Balance at end of period
$

 
$
11,570

 
$
25,000

 
$
36,570

 
$
(57,246
)
 
 
 
 
 
 
 
 
 
 
Six Months Ended June 30, 2016
 
 
 

 
 

 
 

 
 
Balance at beginning of year
$
57,500

 
$
16,368

 
$

 
$
73,868

 
$
(96,048
)
Total gains or (losses) (realized/unrealized)
 
 
 
 
 
 
 
 
 
Included in earnings (1)
(2,500
)
 
161

 

 
(2,339
)
 
(16,121
)
Included in other comprehensive income

 

 

 

 
(37
)
Purchases, issuances, sales and settlements
 
 
 
 
 
 
 
 
 
Purchases

 
776

 

 
776

 

Issuances

 

 

 

 

Sales

 

 

 

 

Settlements
(5,789
)
 

 

 
(5,789
)
 
536

Transfers in and/or out of Level 3

 

 

 

 

Balance at end of period
$
49,211

 
$
17,305

 
$

 
$
66,516

 
$
(111,670
)


(1)
For the 2017 periods, gains or losses were included in net realized gains (losses). For the 2016 periods, losses on asset backed securities were included in net impairment losses recognized in earnings gains or losses while gains or losses on corporate bonds and contingent consideration liabilities were included in net realized gains (losses).